Find out if you are a candidate of the Beat-HF Study

IMPORTANT FACTS: The BeAT Heart Failure Study evaluates an investigational implantable device. The Study has been approved by the FDA and designated as an Expedited Access Pathway (EAP) program due to its potential as a therapy to treat a life-threatening disease with no approved alternative treatment.